MetaCap

Certara (CERT) vs OneMedNet (ONMD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

Certara (CERT) has outperformed OneMedNet (ONMD) over the past year, losing 33.5% versus a loss of 79.0%. Over five years, CERT leads with a -77.2% price change compared with -95.2% for ONMD. Certara is the larger company by market cap ($1.32 billion vs $28.1 million), about 46.9 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CERT-33.54%ONMD-79.04%
+42%-21%-85%
Oct 8, 20251 yearOct 8, 2026
CERT-74.32%ONMD-95.20%
+34%-35%-103%
Oct 4, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CERT versus ONMD key metrics
MetricCERTONMD
Share price$8.64$4.82
Market cap$1.32B$28.08M
1-day change-3.57%-1.83%
YTD return-1.93%-56.18%
1-year return-33.54%-79.04%
5-year return-77.17%-95.21%
Forward P/E22.17—
EPS (TTM)$-0.14$-1.60
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$13.11$42.20
52-week low$4.45$4.73
Distance from 52-week high-34.10%-88.58%
Analyst consensusbuy—
Avg. price target upside+0.81%—
Average volume3.10M114.91K
Shares outstanding152.54M5.82M
Employees1,51522
SectorHealthcareHealthcare
IndustryHealth Information ServicesHealth Information Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Certara is about 46.9 times larger than OneMedNet by market value ($1.32B vs $28.08M).
  • CERT has outperformed ONMD by 45.5 percentage points over the past year.

About Certara

CERT stock →

Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes.

Healthcare · Health Information Services · 1,515 employees

About OneMedNet

ONMD stock →

OneMedNet Corporation, a healthcare software company, provides digital medical image management, exchange, and sharing solutions in the Americas, Europe, and the Middle East. It offers iRWD, which provides regulatory grade imaging and clinical data in the pharmaceutical, device manufacturing, contract research organizations, and artificial intelligence markets markets.

Healthcare · Health Information Services · 22 employees

CERT vs ONMD FAQ

Which is bigger, Certara or OneMedNet?

Certara (CERT) is larger, with a market capitalization of $1.32B compared with $28.08M for OneMedNet (ONMD).

Which stock has performed better over the past year, CERT or ONMD?

CERT returned -33.54% over the past 12 months, compared with -79.04% for ONMD (price return, excluding dividends). Past performance does not predict future results.

Are Certara and OneMedNet in the same industry?

Yes. Both are classified in the Health Information Services industry within the Healthcare sector.

More comparisons